ImmuCell Corporation Investment Income, Interest
ImmuCell Corporation (ICCC) reported Investment Income, Interest of $65.34 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- ImmuCell Corporation investment income, interest for the quarter ending 2026-06-30 was $65.34K, a 35.81% increase year-over-year.
- ImmuCell Corporation investment income, interest for the quarter ending 2026-03-31 was $44.37K, a 18.41% increase year-over-year.
- ImmuCell Corporation investment income, interest for the quarter ending 2025-12-31 was $31.66K, a 12.61% decline year-over-year.
- ImmuCell Corporation investment income, interest for the quarter ending 2025-09-30 was $41.47K, a 121.93% increase year-over-year.
- ImmuCell Corporation investment income, interest for fiscal 2025 was $158.71K, a 104.25% increase from fiscal 2024.
- ImmuCell Corporation investment income, interest for fiscal 2024 was $77.70K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $65.34K 10-Q · filed 2026-08-13 | $109.71K 10-Q · filed 2026-08-13 | $141.37K derived: sum of 3 quarters · filed 2026-08-13 | $182.84K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $44.37K 10-Q · filed 2026-05-14 | $76.03K derived: sum of 2 quarters · filed 2026-05-14 | $117.49K derived: sum of 3 quarters · filed 2026-05-14 | $165.61K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $31.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $73.13K derived: sum of 2 quarters · filed 2026-03-30 | $121.24K derived: sum of 3 quarters · filed 2026-08-13 | $158.71K 10-K · filed 2026-03-30 |
| 2025-09-30 | $41.47K 10-Q · filed 2025-11-13 | $89.58K derived: sum of 2 quarters · filed 2026-08-13 | $127.05K 10-Q · filed 2025-11-13 | $163.28K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $48.11K 10-Q · filed 2026-08-13 | $85.58K 10-Q · filed 2026-08-13 | $121.81K derived: sum of 3 quarters · filed 2026-08-13 | $140.49K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $37.47K 10-Q · filed 2026-05-14 | $73.69K derived: sum of 2 quarters · filed 2026-05-14 | $92.38K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $36.23K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $54.91K derived: sum of 2 quarters · filed 2026-03-30 | $77.70K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $18.68K 10-Q · filed 2025-11-13 | $41.48K 10-Q · filed 2025-11-13 | ||
| 2016-09-30 | $1.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $20.07K 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | $18.48K 10-Q · filed 2016-08-11 | |||
| 2015-12-31 | $9.22K 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |